Urgent FDA Help: Detained Shipments, Import Alerts & Lapsed Agents

When to use this playbook

1. Your shipment is held or detained at entry

Immediate answer: If a customs broker says FDA is holding your shipment, get the Notice of FDA Action, entry number, stated violation, and response deadline before changing registrations or sending documents. The issue may be an FDA detention, missing Prior Notice, a registration or listing mismatch, or a U.S. Agent designation lapse. FDA Entry Point offers same-day crisis response to triage the notice, coordinate the manufacturer, importer, and broker, and correct agent or registration records while the targeted response is prepared. FDA identifies ITACS as its preferred method for entry-document submission and places the applicable “respond by” date on the detention notice. FDA detention and hearing guidance

• Send the complete notice, entry number, product details, port, broker contact, and response deadline.
• Check the ITACS entry status, Prior Notice filing, registration, product listing, and U.S. Agent record against the shipment data.
• Assign one response owner and submit evidence that addresses the violation stated in the notice.

2. Your company or product is on an import alert or Red List

Immediate answer: An FDA import alert can place a firm, product, or country on detention without physical examination (DWPE), meaning future entries may be detained without FDA first examining or testing each shipment. The urgent work is to identify the exact import alert and Red List entry, read its charges and Guidance section, and separate the response for the current detained shipment from any longer-term removal request. FDA Entry Point’s immediate role is to identify registration, listing, Prior Notice, agent, and entry-data defects, coordinate the operational response, and escalate formal import-alert removal or legal defense when the underlying issue goes beyond administrative remediation. FDA import alert guidance

• Confirm the import alert number and whether the firm, product, manufacturer, shipper, or country appears on the Red List.
• Match the Notice of FDA Action to the violation identified in the import alert rather than treating DWPE as a generic paperwork hold.
• Determine whether the immediate path is entry-specific testimony, corrective registration work, supporting technical evidence, import-alert removal, or a combination of these.

3. Your U.S. Agent lapsed, resigned, or missed a renewal

Immediate answer: Treat a U.S. Agent designation lapse as an urgent record-continuity problem when a shipment or FDA deadline is approaching. Confirm when the prior agent stopped serving, recover control of the applicable FDA account, appoint the replacement, complete any required agent-acceptance step, and repair the underlying registration or listing rather than changing only the contact name. Devices use FURLS/DRLM; food, cosmetics, and drugs follow different registration workflows. FDA Entry Point responds to inquiries within 24 business hours and confirms and submits a complete U.S. Agent registration update within one business day once the required information is available; submission does not guarantee the timing of FDA confirmation. FDA Entry Point U.S. Agent process

• Check whether the former agent also controls the official correspondent role, portal credentials, or submission history.
• Give the replacement agent the legal facility name, address, registration identifiers, product vertical, prior-agent details, and any active shipment notice.
• Confirm the new designation in the live FDA record and send the corrected information to the importer and broker before the next entry is filed.

For the narrower continuity problem created by a resignation or uncertain agent status, use the U.S. Agent resignation and lapse playbook.

In each scenario, the goal is not to “become compliant eventually.” The goal is to stop the problem from widening: identify the exact FDA action, restore any broken registration or agent designation, and get the right documents in front of the right FDA system or office before a hold turns into a refusal.

What success looks like

• You know whether the issue is a detention, refusal, import alert, prior notice problem, or registration defect.
• A valid U.S. Agent is on file where required, and the facility or establishment record is updated in the correct FDA system.
• The importer, broker, and manufacturer are working from the same facts and document set.
• The FDA receives a timely, targeted response rather than a generic explanation.
• You have a clear path either to release this shipment or to prevent the next one from being stopped for the same reason.

What we do when your shipment is already held

FDA Entry Point’s lane in an active hold is fast remediation and response coordination, not import-litigation theater. When a shipment is already detained or flagged, the practical job is to read the actual Notice of FDA Action or detention notice, identify the stated hold reason and response deadline, fix the broken FDA record if the trigger is a lapsed U.S. Agent or registration defect, and get the right documents into the right system before the response window closes. For detained entries, FDA directs importers to use ITACS for document submission; other fixes may run through FURLS/DRLM, Prior Notice systems, Cosmetics Direct, or the applicable drug registration and listing workflow. FDA detention and hearing guidance

• Read and interpret the detention notice, Notice of FDA Action, broker message, or refusal notice against the entry number.
• Identify whether the operative problem is detention, import alert exposure, prior notice failure, listing mismatch, or a registration and U.S. Agent lapse.
• Restore a valid U.S. Agent designation or correct the underlying registration or listing defect in the governing FDA system.
• Assemble the targeted response package around the stated violation instead of sending a generic compliance explanation.
• Coordinate one fact pattern across the broker, importer, and foreign manufacturer so product names, codes, addresses, and registration identifiers match.

That matters because many active holds are not won or lost on abstract “FDA experience.” They are won or lost on whether someone can quickly separate the actual trigger from the surrounding noise, correct the record that FDA is looking at, and submit a response that matches the notice. Where the right next step is formal detention-hearing counsel, reconditioning strategy, or a broader legal defense, that is the point to escalate; FDA Entry Point’s role is the operational side of getting the agent, registration, listing, prior notice, and response package moving fast rather than leaving the shipment to drift. FDA actions and enforcement

Fast triage: what problem are you actually dealing with?

FDA import enforcement explains that import alerts support detention without physical examination, while the FDA import alert database is updated in real time.

Step-by-step crisis playbook

1. Freeze assumptions and collect the actual notice

Action: Get the exact FDA or broker notice, entry number, product description, manufacturer name, shipper, port, and date. Ask for screenshots if the message came through a broker portal rather than directly from FDA.

Expected outcome: You know whether you are dealing with detention, refusal, import alert exposure, prior notice failure, or a registration problem.

Gotchas: Teams often say “customs held it” when the operative issue is FDA, and they often say “registration problem” when the real trigger is product coding, labeling, or prior notice. Misreading the first notice wastes the most valuable hours.

Time estimate: Immediate. The point of this step is to get to the actual hold reason and response path fast enough to preserve a release option if one still exists.

2. Confirm the deadline before you build the response

Action: Identify the response window in the detention or hearing notice and confirm who is responsible for submitting documents. If the shipment is food, also confirm whether Prior Notice was filed correctly and on time.

Expected outcome: You know the clock you are working against and whether the next move is documentary, procedural, or both.

Gotchas: If FDA does not receive a response to detention within the specified timeframe, the compliance officer can issue refusal of admission. For food, an invalid or missing Prior Notice can itself lead to a hold or refusal. FDA detention and hearing guidance; FDA Entry Point Prior Notice page

Time estimate: Same day.

3. Check whether your U.S. Agent is valid, reachable, or has resigned

Action: Verify the U.S. Agent on file for the affected facility or establishment and confirm that the agent is still active, monitoring communications, and authorized to coordinate with FDA.

Expected outcome: You know whether the current problem is partly a communication failure.

Gotchas: A lapsed or nonresponsive U.S. Agent does not automatically explain every detention, but it often makes a bad situation worse because FDA notices, inspection coordination, and follow-up questions stop moving. FDA requires foreign device establishments to identify a U.S. Agent as part of registration, and foreign food facility registrations also require a U.S. Agent. FDA device U.S. Agent guidance; FDA foreign food facility Q&A

Time estimate: A few hours if you have account access; longer if the prior provider controls the login trail.

4. Replace or re-designate the U.S. Agent in the correct FDA system

Action: Update the agent designation in the system that governs your vertical: food facility registration, device registration in FURLS/DRLM, cosmetics registration/listing, or the applicable drug establishment and listing workflow.

Expected outcome: FDA has a current U.S.-based contact tied to the affected foreign facility or establishment.

Gotchas: This is where companies lose time by treating all FDA-regulated products as if they use one shared workflow. Devices use FURLS/DRLM for registration and listing, and FDA’s device instructions are explicit that foreign establishments identify the U.S. Agent electronically there. Cosmetics and food have different registration paths and renewal cycles. FDA device registration instructions; FDA cosmetics registration and listing

Time estimate: Often same day to one business day once the right account access and facility details are available.

5. Repair the registration or listing defect, not just the contact record

Action: Check whether the facility registration, establishment registration, or product listing itself is inactive, expired, incomplete, or inconsistent with the shipment documents.

Expected outcome: You separate “agent problem” from “registration problem,” which are related but not identical.

Gotchas: A new U.S. Agent does not cure an expired registration by itself. Foreign drug establishments must register before offering drugs for import and renew annually; device establishments must keep registration and listing current; food and cosmetic records follow their own renewal cadence. FDA importing human drugs guidance; FDA registration and listing overview

Time estimate: Same day to several business days depending on the vertical and whether product-level listings also need correction.

6. Build the response package around the stated violation

Action: Match your documents to the reason FDA gave: registration proof, corrected listing data, label files, prior notice confirmation, product specifications, or other records requested in the notice.

Expected outcome: The response addresses the actual hold reason instead of flooding FDA with irrelevant attachments.

Gotchas: “More documents” is not the same as “better response.” If the issue is labeling, a registration receipt will not solve it. If the issue is prior notice, a general compliance letter will not solve it. For detained entries, FDA directs importers to upload documents through ITACS.

Time estimate: 4–24 hours for straightforward administrative defects; longer if labels, formulations, or listing data need revision.

7. Coordinate one message across manufacturer, importer, and broker

Action: Assign one owner for the response and make sure the broker, U.S. importer, and foreign manufacturer are using the same product names, codes, addresses, and registration identifiers.

Expected outcome: Fewer contradictory submissions and fewer avoidable follow-up questions.

Gotchas: The practical failure mode in urgent cases is not usually “nobody cared.” It is fragmented communication: the broker fixes the entry, the manufacturer updates a registration, and the agent answers a different question, all on separate timelines.

Time estimate: Same day if one person can force alignment quickly.

8. If an import alert is involved, separate shipment release from Red List removal

Action: Look up the exact import alert and determine whether you are trying to clear one shipment, seek removal from detention without physical examination, or both.

Expected outcome: You avoid treating a systemic enforcement status like a one-off paperwork problem.

Gotchas: Import alerts are not generic warnings. FDA uses them when it has enough evidence or information to allow detention without physical examination, and the removal process can be more involved than fixing a single entry. FDA actions and enforcement

Time estimate: Same day to identify; much longer to resolve if the firm or product is on a Red List.

9. Decide whether this shipment is salvageable or whether the real win is preventing the next failure

Action: Ask directly: can this entry still be released if the defect is corrected now, or has the matter moved to refusal, export, or destruction risk?

Expected outcome: You stop spending urgent money on a shipment that cannot realistically be saved and shift effort to reinstatement and future entries if needed.

Gotchas: Some teams stay emotionally attached to the current shipment when the better commercial decision is to fix the registration stack and relaunch the next entry cleanly.

Time estimate: Usually determinable within 1 business day once the notice and status are clear.

10. Put a live owner on renewals and FDA communications after the fire is out

Action: Once the immediate issue is stabilized, assign ongoing responsibility for renewal tracking, notice handling, and vertical-specific filings.

Expected outcome: The same lapse does not recur at the next renewal cycle or next shipment.

Gotchas: The cheapest U.S. Agent arrangement often works until the first real exception. FDA Entry Point combines the U.S. Agent role with communication handling, registration updates, and renewal tracking rather than stopping at mailbox coverage. A planned provider change should also transfer account access, submission history, and responsibility for adjacent filings. Switching FDA U.S. Agents after a missed renewal

Time estimate: 1–5 business days to reset ownership and records properly.

What changes by vertical

Why response speed matters more than price in this moment

Urgent FDA problems compound quickly because the operational cost is not just the consulting fee. It is demurrage, missed launch windows, stockouts, distributor friction, and the risk that the next shipment repeats the same defect. That is why crisis buyers usually stop optimizing for the cheapest annual U.S. Agent and start optimizing for responsiveness, document control, and someone who can tell them which system actually needs fixing.

A response SLA only matters if the provider can also change the record behind the hold. FDA Entry Point combines urgent communication handling with U.S. Agent designation, registration and listing support, Prior Notice work, and renewal tracking across food, cosmetics, medical devices, and drugs. That operating model is more practical than passive message forwarding when a shipment is already detained or the next entry is approaching with an unresolved registration lapse. FDA Entry Point U.S. Agent and compliance process

When FDA Entry Point is and is not the right fix

• FDA Entry Point is the best fit when: the problem is administrative, registration-related, Prior-Notice-related, or tied to a missing, resigned, or failed U.S. Agent relationship.
• FDA Entry Point is often still useful when: the shipment issue spans multiple records and you need one U.S.-based coordinator to align the manufacturer, broker, importer, and FDA-facing response.
• FDA Entry Point is not the whole answer when: the core issue is a substantive product violation, adulteration, unsupported claim set, contested enforcement action, or a deeper quality-system problem. In those cases, U.S. Agent and registration remediation may be necessary, but separate legal, laboratory, or technical support may also be required.

Frequently asked questions

My shipment is held at customs. How fast can FDA Entry Point start?

FDA Entry Point offers same-day crisis response for urgent shipment triage, while its published U.S. Agent service baseline is a response within 24 business hours. The first operational step is to collect the Notice of FDA Action, entry number, product and facility details, port, broker contact, and response deadline. If the hold involves a U.S. Agent designation or registration defect, FDA Entry Point confirms and submits a complete registration update within one business day once the required information is available. FDA Entry Point U.S. Agent process

Can FDA Entry Point help with detention without physical examination or an import-alert Red List?

Yes, FDA Entry Point can triage detention without physical examination (DWPE), identify the exact import alert and Red List entry, coordinate the entry-specific response, and correct connected registration, listing, Prior Notice, or U.S. Agent defects. Import-alert removal is different from clearing one shipment, however, and cases involving contested violations, laboratory evidence, or formal defense may require additional legal or technical support. FDA explains that products on an import alert can be detained without prior physical examination and must overcome the stated appearance of a violation. FDA import alert guidance

My U.S. Agent resigned or missed a renewal. Am I locked out of FURLS?

An agent resignation does not automatically prove that your FURLS account is locked, but the designation, official correspondent role, and account access must be checked immediately. For medical devices, the owner/operator should inspect FURLS/DRLM to determine what FDA currently shows and whether the former provider controls a subaccount or official-correspondent role. Food, cosmetics, and drug records use different workflows, so the replacement must be filed in the system governing the affected facility. U.S. Agent resignation and lockout playbook

Can a replacement U.S. Agent get my detained shipment released by itself?

A replacement U.S. Agent fixes the designation lapse, but it releases a detained shipment only when that was the sole defect and FDA accepts the corrected record. The Notice of FDA Action may also identify an expired registration, missing product listing, Prior Notice error, labeling problem, import alert, or substantive product violation. Replace the agent quickly, but build the response around the actual charges and “respond by” date rather than assuming the contact update resolves the entry. FDA detention and hearing guidance

What should I send first if my broker says FDA is holding the shipment?

Send the complete FDA or broker notice, Customs entry number, product description, manufacturer and shipper names, port, broker contact, shipment status, and stated response deadline. Include screenshots when the status appears only inside a broker portal. Those records make it possible to distinguish an FDA detention from a refusal, import alert, Prior Notice problem, registration defect, listing mismatch, or U.S. Agent designation lapse before anyone starts making changes.

Can FDA Entry Point fix an FDA registration lapse before my next shipment arrives?

FDA Entry Point can prioritize the registration lapse before arrival by identifying the correct FDA system, restoring the U.S. Agent designation, repairing the facility or establishment record, and aligning the corrected identifiers with the importer and broker. The fastest path requires the legal facility name, registration or owner/operator number, portal access, product listings, prior-agent details, and shipment timing. Filing should start before the next entry is submitted because FDA confirmation or agent-acceptance steps can continue after the update itself is sent.

References

• FDA — Detention & Hearing
• FDA — Actions & Enforcement
• FDA — Import Alerts
• FDA — Search Import Alerts
• FDA — U.S. Agents for Medical Devices
• FDA — How to Register and List Devices
• FDA — Cosmetic Facility Registration and Product Listing
• FDA — Importing Human Drugs
• FDA — Registration and Listing Overview
• FDA — Foreign Food Facility Inspection Program Q&A
• FDA Entry Point — Prior Notice for Food Imports
• FDA Entry Point — U.S. Agent Services for Food & Beverage
• FDA Entry Point — U.S. Agent & Compliance Process
• FDA Entry Point — U.S. Agent Resignation and Lapse Response
• FDA Entry Point — Switching U.S. Agents After a Missed Renewal
• FDA Entry Point — Choosing the Right FDA Registered Agent